Kenya Confirms First Ebola Death as Congo Outbreak Strains Regional Defences
Kenya confirmed its first Ebola case and death on Tuesday after a citizen who had travelled from the Democratic Republic of Congo died in Nairobi, prompting authorities to trace his contacts as the region confronts an expanding outbreak with no approved vaccine or specific treatment for the virus responsible.
Health Cabinet Secretary Aden Duale told a news conference that the man had lived in Congo for seven years and had been ill for about a month before travelling overland to Kampala, Uganda, and flying to Nairobi on Saturday, October 3. He had received treatment at several hospitals in Congo before returning to Kenya.
The patient passed through public health screening at Jomo Kenyatta International Airport and was taken to Nairobi Hospital, where clinicians isolated him. He died at about 11:30 p.m. on Monday, October 5, Duale said.
“The patient was given supportive treatment but regrettably passed on last night at around 11.30 pm,” the minister said.
The confirmation extends the regional reach of a crisis that began in Congo in May. According to World Health Organization figures, Congo had recorded 8,463 cases and 4,082 deaths as of October 2. Those figures predate Kenya’s announcement and are not a continent-wide total.
Kenyan officials had announced one confirmed case at Tuesday’s briefing. The contacts being traced were people potentially exposed to the patient, rather than additional confirmed infections. Duale sought to reassure the public while outlining measures to prevent further transmission.
“I wish to reassure the public not to panic, as all systems are in place to mitigate the spread of the disease,” he said.
Authorities identified 28 contacts, including relatives and healthcare workers, and were also tracing 23 passengers and four crew members from the patient’s flight. Quarantine arrangements had been prepared for those assessed to be at risk.
The patient arrived at hospital with fever, chills, severe fatigue, muscle pain and bleeding beneath the skin at an injection site. He was initially isolated in the emergency department before being moved to the hospital’s East Wing isolation facility. Duale said a burial following Ebola-safe public health protocols was being arranged.
Kenya’s Director-General for Health, Patrick Amoth, said medication may have masked the patient’s symptoms during airport screening, according to Reuters. His account raises questions about how an ill traveller passed through screening before clinicians recognised the infection.
Laboratory testing confirmed Bundibugyo virus disease, the form of Ebola driving the Congolese outbreak. Kenya’s Health Ministry said it had tested 267 samples across five laboratories since May, with only this sample returning positive. It also reported training 4,971 health workers and deploying mobile laboratories at the Busia and Lwakhakha border crossings.
Congo remains the centre of the emergency. In an assessment published in August, WHO described the outbreak as the largest Ebola epidemic ever documented in the country. Insecurity, displacement and attacks on healthcare facilities have disrupted surveillance and treatment, while fear and mistrust have discouraged some patients from seeking care.
The pressure is increasingly visible in North Kivu. Médecins Sans Frontières said on October 5 that the province accounted for nearly 40 percent of newly confirmed cases nationwide, up from 24 percent at the end of August. New hotspots were appearing weekly, while treatment capacity remained insufficient.
“It is like fighting a megafire,” said Stephanie Hoffmann, MSF’s coordinator at the Ebola treatment centre in Butembo.
MSF said it was sometimes forced to refer confirmed patients elsewhere because beds were unavailable. The organisation warned that expanding facilities alone would not contain the outbreak: people must also trust response teams enough to seek treatment early and accept isolation.
More than 60 percent of Ebola-related deaths continued to occur in the community, MSF said in its update. It called for urgent investment in treatment capacity and access to quality care across North Kivu.
WHO has reported substantial expansion of Congo’s response, alongside continuing shortages. Between July 27 and September 21, treatment capacity increased from 929 to 1,510 beds across 54 health facilities. More than 1,400 additional health professionals were needed to support the expansion.
“Rapid isolation and treatment of cases is essential,” said Dr. Stéphane Mutombo, a Congolese health ministry official overseeing clinical care, in WHO’s September 30 update.
The government’s revised six-month response plan, launched in September with international partners, requires $1.3 billion. WHO said poor roads, long distances and insecurity continued to obstruct access despite improvements in laboratories, surveillance and patient transport.
The virus itself presents another constraint. Approved vaccines and treatments for Ebola caused by the Zaire species cannot be assumed effective against Bundibugyo. WHO has supported research into possible treatments and recommended that the licensed Ervebo vaccine be studied in a randomised trial during the Congolese outbreak. Its use in research does not establish protection against Bundibugyo.
The absence of an approved specific treatment does not mean patients cannot receive care. WHO says early intensive supportive treatment, including rehydration and management of symptoms and complications, can improve survival.
Ebola spreads through direct contact with the blood or other bodily fluids of an infected person who is symptomatic or has died, or with contaminated objects. Healthcare workers and people caring for sick relatives face particular risks when infection-control precautions are inadequate. Direct contact with bodies during funerals can also transmit the virus.
Uganda’s experience offers evidence that transmission can be interrupted. WHO and Africa CDC announced the end of its Bundibugyo outbreak on August 27, after 42 consecutive days without a new confirmed case following the discharge of its last patient. Uganda recorded 20 confirmed cases during that outbreak.
“This is a victory for Uganda and an important lesson for our continent,” Africa CDC Director-General Jean Kaseya said at the time.
Kenya’s immediate task is to establish whether the imported infection led to further cases by finding exposed people and detecting illness quickly.
Comments